Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients.
Erice
A
A
Department of Laboratory Medicine and Pathology, University of Minnesota Health Sciences Center, Minneapolis.
Chou
S
S
Biron
K K
KK
Stanat
S C
SC
Balfour
H H
HH
Jordan
M C
MC
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications; D000212:Acyclovir / Q000031:analogs & derivatives* / Q000494:pharmacology; D000328:Adult; D000998:Antiviral Agents / Q000494:pharmacology*; D003587:Cytomegalovirus / Q000187:drug effects* / Q000302:isolation & purification; D003586:Cytomegalovirus Infections / Q000209:etiology*; D004279:DNA, Viral / Q000032:analysis; D004352:Drug Resistance, Microbial; D005260:Female; D015774:Ganciclovir; D006801:Humans; D007108:Immune Tolerance; D007165:Immunosuppression Therapy / Q000009:adverse effects; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications; D008297:Male; D008875:Middle Aged; D012173:Retinitis / Q000209:etiology
D000998:Antiviral Agents; D004279:DNA, Viral; D015774:Ganciclovir; D000212:Acyclovir